
This is a joint position between the Kalish and Kheir Laboratories at Boston Children’s Hospital. Dr. Kalish’s lab seeks to develop new therapies to protect the fetal and newborn brain from injury. Dr. Kheir’s lab (The Translational Research Lab) seeks to improve the standard of care in pediatric and adult cardiovascular critical care medicine. Both Dr. Kalish and Dr. Kheir are working collaboratively to advance new treatments applicable for critically ill infants and children. This work spans preclinical animal models (including rodents and large animals, such as pigs and sheep) to early phase human clinical trials.
This position will be co-supervised by Drs. Kalish and Kheir. The primary responsibility will be the management of supply of hydrogen gas used for multiple ongoing clinical trials. Other responsbilities will include contributing to the organization of preclinical animal studies and other human-based clinical research studies. Ideally, a successful candidate would be able to make a minimum 18-month commitment. This would be an ideal position for a student interested in medicine who is seeking to gain exposure to translational research.
Full-Time
Regular
40
$44657.60-$69773.60 Annual
Boston
Research
Onsite Only

Boston Children's Hospital is a 404-bed comprehensive center for pediatric health care. As one of the largest pediatric medical centers in the United States, Boston Children's offers a complete range of health care services for children from birth through 21 years of age. (Our services can begin interventions at 15 weeks gestation and in some situations we also treat adults.)
We have approximately 25,000 inpatient admissions each year and our 200+ specialized clinical programs schedule 557,000 visits annually. Last year, the hospital performed more than 26,500 surgical procedures and 214,000 radiological examinations.
Our team of physicians and nurses has been recognized by a number of independent organizations for overall excellence, and we're proud to share some notable examples with you here.